Washington State University
3
21M
2
0.02
0.33
1
- Areas of investment
Summary
Washington State University is the famous Corporate Investor, which was founded in 1890. The main department of described Corporate Investor is located in the Pullman. The fund was located in North America if to be more exact in United States.
Among the most popular portfolio startups of the fund, we may highlight Corus Pharma. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The higher amount of exits for fund were in 2006. The common things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2004. The fund is constantly included in less than 2 deals per year. The typical startup value when the investment from Washington State University is 50-100 millions dollars.
The usual cause for the fund is to invest in rounds with more than 10 partakers. Despite the Washington State University, startups are often financed by JPMorgan Partners (JPMP), RBC Capital Markets, OrbiMed. The meaningful sponsors for the fund in investment in the same round are WestRiver Group, LLC, SunAmerica Ventures, RBC Capital Markets.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Artificial Intelligence (2)
- Life Science (2)
- Machine Learning (2)
- Pharmaceutical (1) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 182M
- Group Appearance index
- 0.33
- Avg. company exit year
- 5
- Avg. multiplicator
- 2.43
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Corus Pharma | 13 Apr 2004 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 65M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.